Literature DB >> 3043345

[In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].

L Dubreuil1, J Devos, H Beerens, C Romond.   

Abstract

The activity of metronidazole combined with ofloxacin was investigated by the checkerboard method in liquid medium against 60 obligate anaerobes. The bacteriostatic effect of the combination was assessed by calculating the FIC index. Two metronidazole resistant strains of Propionibacterium acnes (MIC greater than 32 mg/l) were inhibited by 0.125 mg/l of this former antibiotic in presence of an ofloxacin concentration equal to half the value of the MIC. On the 58 other anaerobic strains, the combination of metronidazole plus ofloxacin had an additive bacteriostatic effect (30 strains) or a synergistic effect (26 strains). No antagonism was noted with any strain. For selected anaerobic or mixed infections the combination of metronidazole and ofloxacin may be useful. Killing curves demonstrated that, under good anaerobic conditions, metronidazole acted rapidly against Bacteroides fragilis. At a concentration of 8 mg/l, a decrease of log10 of the population was observed after 2 hours. After a contact ranging from 1 to 8 hours, depending of the investigated strains, a bactericidal effect was observed with metronidazole.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043345

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

1.  Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.

Authors:  W R Heizmann; R Schmid; F Heilmann; H Werner
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

2.  [Susceptibility of clinically important Bacteroides species against enoxacin-metronidazole and enoxacin-clindamycin combinations].

Authors:  W R Heizmann; H Werner; R Schmid
Journal:  Infection       Date:  1989       Impact factor: 3.553

Review 3.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

4.  A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.

Authors:  Seng-Kee Chuah; Chih-Ming Liang; Chen-Hsiang Lee; Shue-Shian Chiou; Yi-Chun Chiu; Ming-Luen Hu; Keng-Liang Wu; Lung-Sheng Lu; Yeh-Pin Chou; Kuo-Chin Chang; Chung-Huang Kuo; Chung-Mou Kuo; Tsung-Hui Hu; Wei-Chen Tai
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  Levofloxacin based vs clarithromycin based sequential therapy in helicobacter pylori eradication; a randomized clinical trial.

Authors:  Mosayeb Moradniani; Zohre Mirbeik-Sabzevari; Soleiman Jaferian; Shiva Shafiezadeh; Mohammad Javad Ehsani Ardakani; Mehrdad Mirzaee Roozbahany; Saleh Azadbakht; Hamidreza Sherkatolabbasieh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.